News - Pfizer, Vaccines


Current filters:


Popular Filters

Positive top-line results for Pfizer’s Prevenar 13 in pneumonia in over 65s


US pharma behemoth Pfizer says that top-line results from a study of Prevenar 13 (pneumococcal 13-valent…

Antibiotics and Infectious diseasesPfizerPharmaceuticalPrevenarResearchVaccines

Leading Chinese hepatitis B vaccine makers stop production; Pfizer drug import halted


China’s Food and Drug Administration announced on January 2 that the country’s three leading manufacturers…

Anti-viralsAntibiotics and Infectious diseasesAsia-PacificBioKangtaiChinaFluconazolePfizerPharmaceuticalRegulationVaccines

Pfizer tasked with novel vaccine research by US government department

Pfizer tasked with novel vaccine research by US government department


Pfizer, the world’s largest drugmaker by sales, has been awarded a nearly $7.7 million technology investment…

North AmericaPfizerPharmaceuticalResearchVaccines

New Zealand views addition of rotavirus, varicella vaccines to national immunization schedule


A vaccine for the gastric infection rotavirus and protection from varicella for the most vulnerable people…

FinancialHealthcareNew ZealandPfizerPharmaceuticalPrevenarVaccines

Updated EU labeling for Pfizer’s Prevenar 13

Updated EU labeling for Pfizer’s Prevenar 13


The European Commission has approved updates to the Summary of Product Characteristics for US pharma…


GAVI Alliance gets reduced price offers from Pfizer and GSK


The price that the GAVI Alliance, a public/private partnership, pays for lifesaving pneumococcal vaccines…


Pfizer gets EU approval for Prevenar 13 for adults aged 18-49


US drug giant Pfizer (NYSE: PFE) has today received European approval for an expanded indication of its…


Adult vaccines market controlled by GSK and Merck


The adult vaccines market has been forecast to increase at a compound annual growth rate (CAGR) of 5.6%…

CervarixGardasilGlaxoSmithKlineMarkets & MarketingMerck & CoPfizerPharmaceuticalPrevnarVaccines

Licensing deals for Philogen with Pfizer and GlycoVaxyn with Janssen


Privately held Italian biopharma firm Philogen SpA (Siena, Italy) has granted global drugs behemoth Pfizer…

BiotechnologyDekavilGlycoVaxynInflammatory diseasesJanssenJohnson & JohnsonLicensingPfizerPharmaceuticalPhilogenVaccines

Batch of mixed opinions from FDA advisory panels


Advisory panels of the US Food and Drug Administration meeting yesterday came back with a mixture of…

carfilzomibKyprolisMerck & CoNorth AmericaOncologyOnyx PharmaceuticalsPfizerPharmaceuticalPneumovaxPrevnarRegulationSanofisemuloparinVaccines

Expanded use for Pfizer’s Prevnar 13


Following a previous US Food and Drug Administration advisory panel recommendation (The Pharma Letter…

North AmericaPfizerPharmaceuticalPrevnarRegulationVaccines

US FDA backs SC form of B-MS Orencia; extends review of Pfizer’s Prevnar 13


The US Food and Drug Administration has approved a subcutaneous (SC) formulation of drug major Bristol-Myers…

Anti-Arthritics/RheumaticsBristol-Myers SquibbNorth AmericaOrenciaPfizerPharmaceuticalPrevnarRegulationVaccines

European Medicines Agency updates on pioglitazone, Pandemrix and Champix


Yesterday saw a batch of recommendations from the European Medicines Agency’s advisory body, including…

ActosChampixDiabetesEuropeGlaxoSmithKlineNeurologicalPandemrixPfizerPharmaceuticalRegulationTakeda PharmaceuticalsVaccines

Back to top